1059 related articles for article (PubMed ID: 25579460)
1. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
[TBL] [Abstract][Full Text] [Related]
2. Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution.
Li X; Ma Z; Styblo TM; Arciero CA; Wang H; Cohen MA
Breast Cancer Res Treat; 2021 Feb; 185(3):573-581. PubMed ID: 33068196
[TBL] [Abstract][Full Text] [Related]
3. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
[TBL] [Abstract][Full Text] [Related]
4. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
[No Abstract] [Full Text] [Related]
5. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy.
Liberman L; Holland AE; Marjan D; Murray MP; Bartella L; Morris EA; Dershaw DD; Wynn RT
AJR Am J Roentgenol; 2007 Mar; 188(3):684-90. PubMed ID: 17312054
[TBL] [Abstract][Full Text] [Related]
6. Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy.
Srour MK; Donovan C; Chung A; Harit A; Dadmanesh F; Giuliano AE; Amersi F
Breast J; 2020 Apr; 26(4):679-684. PubMed ID: 31562689
[TBL] [Abstract][Full Text] [Related]
7. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
Berg WA; Mrose HE; Ioffe OB
Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
[TBL] [Abstract][Full Text] [Related]
8. Predictors of underestimation of malignancy after image-guided core needle biopsy diagnosis of flat epithelial atypia or atypical ductal hyperplasia.
Yu CC; Ueng SH; Cheung YC; Shen SC; Kuo WL; Tsai HP; Lo YF; Chen SC
Breast J; 2015; 21(3):224-32. PubMed ID: 25772033
[TBL] [Abstract][Full Text] [Related]
9. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.
Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ
Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416
[TBL] [Abstract][Full Text] [Related]
10. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
[TBL] [Abstract][Full Text] [Related]
11. Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy.
Prowler VL; Joh JE; Acs G; Kiluk JV; Laronga C; Khakpour N; Lee MC
Breast; 2014 Aug; 23(4):352-6. PubMed ID: 24518220
[TBL] [Abstract][Full Text] [Related]
12. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
Kunju LP; Kleer CG
Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
[TBL] [Abstract][Full Text] [Related]
13. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia?
Ibrahim N; Bessissow A; Lalonde L; Mesurolle B; Trop I; Lisbona A; El-Khoury M
AJR Am J Roentgenol; 2012 Feb; 198(2):288-91. PubMed ID: 22268170
[TBL] [Abstract][Full Text] [Related]
15. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.
Cha E; Ambinder EB; Oluyemi ET; Mullen LA; Panigrahi B; Rossi J; Di Carlo PA; Myers KS
Breast Cancer Res Treat; 2022 Dec; 196(3):517-525. PubMed ID: 36242709
[TBL] [Abstract][Full Text] [Related]
16. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
17. High-risk lesions at MRI-guided breast biopsy: frequency and rate of underestimation.
Lourenco AP; Khalil H; Sanford M; Donegan L
AJR Am J Roentgenol; 2014 Sep; 203(3):682-6. PubMed ID: 25148176
[TBL] [Abstract][Full Text] [Related]
18. Pure flat epithelial atypia identified on core needle biopsy does not require excision.
Liu C; Dingee CK; Warburton R; Pao JS; Kuusk U; Bazzarelli A; Sidhu R; McKevitt EC
Eur J Surg Oncol; 2020 Feb; 46(2):235-239. PubMed ID: 31685259
[TBL] [Abstract][Full Text] [Related]
19. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
20. High risk breast lesions identified on MRI-guided vacuum-assisted needle biopsy: outcome of surgical excision and imaging follow-up.
Speer ME; Huang ML; Dogan BE; Adrada BE; Candelaria RP; Hess KR; Hansakul P; Yang WT; Rauch GM
Br J Radiol; 2018 Oct; 91(1090):20180300. PubMed ID: 29947265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
